Ning Xie

6.3k total citations
240 papers, 4.7k citations indexed

About

Ning Xie is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ning Xie has authored 240 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 54 papers in Cancer Research and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ning Xie's work include Natural product bioactivities and synthesis (27 papers), Cancer-related molecular mechanisms research (21 papers) and Phytochemistry and Biological Activities (19 papers). Ning Xie is often cited by papers focused on Natural product bioactivities and synthesis (27 papers), Cancer-related molecular mechanisms research (21 papers) and Phytochemistry and Biological Activities (19 papers). Ning Xie collaborates with scholars based in China, Canada and United States. Ning Xie's co-authors include Xuesen Dong, Martin Gleave, Wenyuan Liu, Feng Feng, Stephen R. Plymate, Hui Sun, Xijun Wang, Shihua Sun, Aihua Zhang and Elahe A. Mostaghel and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ning Xie

223 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Xie China 34 2.8k 1.1k 809 473 449 240 4.7k
Xu Wu China 37 2.4k 0.9× 846 0.8× 369 0.5× 806 1.7× 448 1.0× 138 4.5k
Ye Yang China 37 3.1k 1.1× 1.1k 1.0× 334 0.4× 742 1.6× 224 0.5× 231 4.9k
Chi‐Tai Yeh Taiwan 42 3.1k 1.1× 1.1k 1.0× 468 0.6× 1.1k 2.3× 268 0.6× 167 5.6k
Jianye Zhang China 44 2.7k 1.0× 870 0.8× 336 0.4× 684 1.4× 282 0.6× 178 4.7k
Tao Shen China 33 1.9k 0.7× 595 0.5× 464 0.6× 698 1.5× 227 0.5× 141 3.7k
Cheng Zhang China 39 2.3k 0.8× 695 0.6× 518 0.6× 389 0.8× 241 0.5× 184 4.6k
Elaine Lai‐Han Leung Macao 40 2.6k 0.9× 748 0.7× 545 0.7× 1.1k 2.4× 280 0.6× 143 4.7k
Chin-Wen Ho Taiwan 5 2.6k 0.9× 989 0.9× 899 1.1× 423 0.9× 125 0.3× 7 4.5k
Yong Wu China 42 2.3k 0.8× 807 0.7× 596 0.7× 427 0.9× 159 0.4× 160 4.8k
Yuanyuan Zhang China 37 2.0k 0.7× 645 0.6× 381 0.5× 399 0.8× 240 0.5× 209 4.7k

Countries citing papers authored by Ning Xie

Since Specialization
Citations

This map shows the geographic impact of Ning Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Xie more than expected).

Fields of papers citing papers by Ning Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Xie. The network helps show where Ning Xie may publish in the future.

Co-authorship network of co-authors of Ning Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Xie. A scholar is included among the top collaborators of Ning Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Xie. Ning Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Chunhong, Jia Wang, Xiaoqian Wu, et al.. (2025). Andrographolide sulfonate alleviates rheumatoid arthritis by inhibiting glycolysis-mediated activation of PI3K/AKT to restrain Th17 cell differentiation. Chinese Journal of Natural Medicines. 23(4). 480–491. 2 indexed citations
2.
Zhang, Meiling, Ning Xie, Chunxia Wu, et al.. (2025). Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity. Colloids and Surfaces B Biointerfaces. 259. 115284–115284.
3.
Lin, Jie, et al.. (2024). The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review. World Journal of Surgical Oncology. 22(1). 42–42. 2 indexed citations
4.
Xie, Ning, Zedong Li, Bin Li, et al.. (2024). Invited Review for 20th Anniversary Special Issue of PLRev “AI for Mechanomedicine”. Physics of Life Reviews. 51. 328–342. 3 indexed citations
5.
Zhou, Yan, et al.. (2024). Survival analysis of gynecological cancers in Southeast China, 2011–2020: A population-based study. Cancer Epidemiology. 92. 102641–102641. 1 indexed citations
6.
Zhu, Lianqing, Lidan Lu, Weiqiang Chen, et al.. (2024). MBE growth of mid-wavelength type II InAs/InAsSb superlattice photodetectors with wet etching and Al2O3 passivation. Vacuum. 224. 113087–113087. 3 indexed citations
7.
Zhang, Yumeng, Xiaodan Wang, Baorong Chen, et al.. (2024). The effect of agar on rheological properties and thermal stability of rennet-induced casein micelle gel. Colloids and Surfaces A Physicochemical and Engineering Aspects. 686. 133273–133273. 7 indexed citations
8.
Zhou, Tong, et al.. (2024). The application of nanoparticles in delivering small RNAs for cancer therapy. Discover Oncology. 15(1). 500–500. 3 indexed citations
9.
Xie, Ning, et al.. (2024). A case of relieving thymoma after conservative management of anti‐gamma‐aminobutyric acid receptor type A encephalitis. Thoracic Cancer. 15(24). 1822–1824. 1 indexed citations
10.
Dong, Changyin, Zhihua Xiong, Chu Zhang, et al.. (2024). A transformer-based approach for deep feature extraction and energy consumption prediction of electric buses based on driving distances. Applied Energy. 380. 123941–123941. 4 indexed citations
12.
Lin, Jie, et al.. (2023). A novel nomogram and risk stratification for early metastasis in cervical cancer after radical radiotherapy. Cancer Medicine. 12(24). 21798–21806. 4 indexed citations
14.
Luo, Jindan, Yinan Li, Wei Zheng, et al.. (2019). Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene. Molecular Therapy — Nucleic Acids. 18. 916–926. 31 indexed citations
15.
Li, Haolong, Ning Xie, Ruiqi Chen, et al.. (2016). UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling. Cancer Research. 76(22). 6701–6711. 36 indexed citations
16.
Xie, Ning. (2015). Design and simulation of 3D flexible tactile / thermal sensor. Transducer and Microsystem Technologies. 1 indexed citations
17.
Zhang, Yingzhi, Aihua Zhang, Guangli Yan, et al.. (2013). High-throughput metabolomic approach revealed the acupuncture exerting intervention effects by perturbed signatures and pathways. Molecular BioSystems. 10(1). 65–73. 14 indexed citations
18.
Xie, Ning. (2009). Therapeutic effects of Okam on asthmatic mice. Zhongguo haiyang yaowu. 1 indexed citations
19.
Xie, Ning. (2009). Study on Chemical Constituents from Salacia amplifolia. The Chinese Journal of Modern Applied Pharmacy. 3 indexed citations
20.
Xie, Ning, et al.. (1996). Studies on Derivatives of Teucvidin from Teucrium quadrifarium. Gaodeng xuexiao huaxue xuebao. 17(3). 405.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026